Male Engagement in PMTCT Services

NCT01903889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3806

Last updated 2015-01-09

No results posted yet for this study

Summary

The study employs a quasi-experimental design in 8 public health centers in southwest Uganda offering care and treatment (C\&T) services. In 4 health centers, a basic intervention is introduced, whereby HIV/AIDS providers are trained on contraception for HIV-positive women. They are charged with counseling C\&T clients on FP; offering condoms, pills and injectables; and referring clients for other FP methods. In the other 4 health centers, the basic intervention is introduced along with an intervention for constructive male engagement in HIV and FP services. This includes training of C\&T providers on gender-based influences on health behaviors; provision of couples' HIV testing and FP counseling services; and community-based education for men to promote gender equitable norms and male participation in health services.

Conditions

Interventions

OTHER

clinic based intervention

counseling C\&T clients on FP; offering condoms, pills and injectables; and referring clients for other FP methods

OTHER

clinic and community based intervention

basic intervention is introduced along with an intervention for constructive male engagement in HIV and FP services

Sponsors & Collaborators

  • Elizabeth Glaser Pediatric AIDS Foundation

    collaborator OTHER
  • Mbarara University of Science and Technology

    collaborator OTHER
  • FHI 360

    lead OTHER

Principal Investigators

  • Theresa Hoke, Ph.D., MPH · FHI 360

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-05-31
Completion
2014-08-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01903889 on ClinicalTrials.gov